Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. HOOD
8. DFTX
9. MU
10. IBM

Go back to Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Vir Biotechnology Inc. (VIR) Tops Q4 EPS by 22c, Beats on Revenue

February 22, 2024 4:08 PM EST

Vir Biotechnology Inc. (NASDAQ: VIR) reported Q4 EPS of ($0.86), $0.22 better than the analyst estimate of ($1.08). Revenue for the quarter came in at $16.8 million versus the consensus estimate of $12.07 million.

For earnings history and earnings-related data on Vir Biotechnology Inc. (VIR) click here.

... More